drugset / Trial / NCT00004826

Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease

NCT00004826

Completed 60 enrolled Memorial Hospital of Rhode Island
RandomizedDouble-blindTreatment

Summary

OBJECTIVES: I. Determine the efficacy and tolerability of clozapine in ameliorating psychosis in patients with idiopathic Parkinson's disease (PD). II. Determine the adverse effects of clozapine on motor function in this patient population. III. Determine the safety of clozapine in psychotic PD patients taking multiple anti-PD medications. IV. Describe the phenomenology of drug induced psychosis in PD.

Timeline

Start
1993-10
Primary completion
Completion
1997-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Clozapine Other / unclassified Oral

Indications